P3‐052: A NOVEL CANNABINOID RECEPTOR 1 ANTAGONIST ALLEVIATES METABOLIC DISORDER AND NEUROINFLAMMATION IN THE MODELS OF ALZHEIMER'S DISEASE. (1st July 2019)